 Actinium Pharmaceuticals, Inc. NYSE AMERICAN: ATNM Actinium or the Company today announced the closing of the Companys previously announced underwritten public offering of 210,833,334 shares of common stock or common stock equivalents in lieu thereof at an effective public offering price of 0.15 per share of common stock or common stock equivalent, which includes the full exercise of the underwriters option to purchase additional shares of common stock. 